December 16, 2024 23:54 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
GRAP 4 restrictions reimposed in Delhi as air quality dips to 'severe' category | 39 ministers included in Devendra Fadnavis-led Maharashtra cabinet | People who raise questions on EVMs should show how they can be hacked: TMC trashes Congress claims | Bangladesh likely to hold national polls in late 2025 or early 2026, says Yunus in Victory Day speech | Constitution stood test of time: Nirmala Sitharaman in Rajya Sabha | PM Museum requests Rahul Gandhi to return Pandit Nehru's historical letters | Indian tabla maestro Zakir Hussain dies at 73 in San Francisco, confirms family | Kolkata woman strangled, beheaded and chopped into pieces for refusing brother-in-law's advances | Arvind Kejriwal, CM Atishi to contest Delhi polls from current constituencies | Atul Subhash suicide case: Wife Nikita, her mother and brother arrested
SII buys 50 pc stake in pharma packaging firm Schott Kaisha

SII buys 50 pc stake in pharma packaging firm Schott Kaisha

Aug 18, 2021, at 06:41 am

Pune/IBNS: Pune-based manufacturer of AstraZeneca vaccine, Covishield, Serum Institute of India (SII) has acquired a 50 per cent stake in SCHOTT Kaisha to become SCHOTT's joint venture partner and secure the pharma packaging supply, the pharma company announced on Tuesday.

Boris Johnson announces Serum Institute of India to invest 240 million pounds in UK

Boris Johnson announces Serum Institute of India to invest 240 million pounds in UK

May 04, 2021, at 05:09 pm

London: British PM Boris Johnson has announced the Serum Institute of India (SII), the manufacturers of COVID-19 vaccine Covishield, will be investing 240 million pounds in the United Kingdom through the opening of a new sales office, media reports said.